Login
← Go Back
Hikal
HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com
Stock Price vs Company Growth
1d
2.5%
1w
7.5%
1m
10.9%
3m
11.8%
6m
22.5%
1y
54.5%
5y
2.3%
10y
8.3%
all
8.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 188 2.5%
146
228
Company Overview
Sales
1,746 Cr
Growth: -8.9%
Profit after Tax
-13 Cr
Growth: -228.7%
Small Cap
2,313 Cr
P/S: 1.3x
Industry P/S: 2.4x
Fundamentals
Sales (Cr) ₹ 1,746
Growth -8.9%
EBITDA 13.7%
P/S 1.3x
Dividend 0.4%
P/E -177.0x
Book Value ₹ 97.3
PEG Ratio 19.9x
ROE -1.1%
P/B 1.9x
Shareholding Pattern
Institutions
Government Pension Fund Global
2.31 %
Promoters
Kalyani Investment Company Limited
31.36 %
Shri Badrinath Investment Pvt Ltd
16.15 %
Shri Rameshwara Investment Pvt Ltd
7.96 %
Sugandha Jai Hiremath
7.84 %
Bf Investment Limited
2.65 %
Others
Si Investments And Broking Private Limited
1.62 %
Llp
0.4 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.
Belongs to (8 Indices) view more
Investors (64)
idfc.ste...
bf.inves...
sameer.j...
Followers (6)
mike2
nitin29
vishal48